Citadel Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-616,500
Closed -$131M 15586
2023
Q3
$131M Buy
616,500
+470,000
+321% +$93.9M 0.03% 494
2023
Q2
$28.2M Buy
146,500
+29,500
+25% +$5.86M 0.01% 1540
2023
Q1
$23.7M Buy
117,000
+1,700
+1% +$273K 0.01% 1759
2022
Q4
$14.8M Buy
115,300
+60,600
+111% +$7.82M ﹤0.01% 2315
2022
Q3
$7.49M Sell
54,700
-55,400
-50% -$9.03M ﹤0.01% 3196
2022
Q2
$19.5M Buy
110,100
+68,500
+165% +$9.87M 0.01% 1870
2022
Q1
$5.99M Sell
41,600
-28,800
-41% -$3.9M ﹤0.01% 3834
2021
Q4
$10.9M Sell
70,400
-26,100
-27% -$4.37M ﹤0.01% 2930
2021
Q3
$16.4M Buy
96,500
+22,600
+31% +$3.52M ﹤0.01% 2293
2021
Q2
$11.7M Sell
73,900
-11,200
-13% -$1.66M ﹤0.01% 2837
2021
Q1
$11.8M Sell
85,100
-8,200
-9% -$1.32M ﹤0.01% 2733
2020
Q4
$16.3M Buy
93,300
+15,100
+19% +$2.82M ﹤0.01% 2027
2020
Q3
$15.3M Buy
78,200
+8,100
+12% +$1.36M ﹤0.01% 1814
2020
Q2
$11.9M Buy
70,100
+47,900
+216% +$7.15M ﹤0.01% 2029
2020
Q1
$2.56M Sell
22,200
-3,300
-13% -$365K ﹤0.01% 3740
2019
Q4
$2.91M Sell
25,500
-81,000
-76% -$8.59M ﹤0.01% 3821
2019
Q3
$9.1M Buy
106,500
+67,800
+175% +$4.97M ﹤0.01% 2327
2019
Q2
$2.68M Sell
38,700
-35,300
-48% -$2.47M ﹤0.01% 4043
2019
Q1
$5.42M Buy
74,000
+44,900
+154% +$3.19M ﹤0.01% 2886
2018
Q4
$1.65M Buy
29,100
+12,800
+79% +$803K ﹤0.01% 4458
2018
Q3
$1.26M Sell
16,300
-5,400
-25% -$398K ﹤0.01% 5150
2018
Q2
$1.44M Sell
21,700
-7,500
-26% -$430K ﹤0.01% 4611
2018
Q1
$1.53M Sell
29,200
-11,300
-28% -$616K ﹤0.01% 4146
2017
Q4
$2.17M Buy
40,500
+13,700
+51% +$800K ﹤0.01% 3527
2017
Q3
$1.46M Buy
26,800
+6,300
+31% +$323K ﹤0.01% 3799
2017
Q2
$1.06M Buy
20,500
+5,500
+37% +$350K ﹤0.01% 3997
2017
Q1
$943K Sell
15,000
-3,000
-17% -$187K ﹤0.01% 4090
2016
Q4
$950K Sell
18,000
-100
-0.6% -$6.01K ﹤0.01% 3929
2016
Q3
$978K Buy
18,100
+6,900
+62% +$327K ﹤0.01% 3865
2016
Q2
$453K Sell
11,200
-2,500
-18% -$95.1K ﹤0.01% 4631
2016
Q1
$481K Sell
13,700
-1,300
-9% -$43.7K ﹤0.01% 4469
2015
Q4
$673K Sell
15,000
-10,000
-40% -$416K ﹤0.01% 4086
2015
Q3
$964K Sell
25,000
-12,600
-34% -$567K ﹤0.01% 3875
2015
Q2
$1.82M Sell
37,600
-12,000
-24% -$495K ﹤0.01% 3169
2015
Q1
$1.75M Buy
49,600
+700
+1% +$23.9K ﹤0.01% 3233
2014
Q4
$1.57M Sell
48,900
-7,000
-13% -$244K ﹤0.01% 3198
2014
Q3
$2.08M Buy
55,900
+28,100
+101% +$1.11M ﹤0.01% 2810
2014
Q2
$1.06M Buy
27,800
+8,900
+47% +$336K ﹤0.01% 3414
2014
Q1
$861K Sell
18,900
-11,500
-38% -$550K ﹤0.01% 3622
2013
Q4
$1.21M Buy
30,400
+1,600
+6% +$65.3K ﹤0.01% 3032
2013
Q3
$1.26M Buy
28,800
+9,700
+51% +$404K ﹤0.01% 2859
2013
Q2
$601K Buy
+19,100
New +$666K ﹤0.01% 3658

Other funds holding SGEN

Citadel Advisors's SGEN Position: Q4 2023 in Review

Citadel Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,428,418 shares — an estimated $515M sold.

Citadel Advisors first reported a position in SGEN in Q2 2013 and held it in 39 quarters. The position peaked at $515M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Citadel Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 2,428,418 Seagen Inc. Common Stock shares in Q4 2023, an estimated $515M.
  • Citadel Advisors first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 39 quarters.
  • Citadel Advisors's Seagen Inc. Common Stock position peaked at $515M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.